Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • Institutional usage stats (logged-in users only)
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • Institutional usage stats (logged-in users only)
Research Article
The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing
Hitoki Hasegawa, Toshinori Hyodo, Eri Asano, Satoko Ito, Masao Maeda, Hirokazu Kuribayashi, Atsushi Natsume, Toshihiko Wakabayashi, Michinari Hamaguchi, Takeshi Senga
Journal of Cell Science 2013 126: 3627-3637; doi: 10.1242/jcs.124818
Hitoki Hasegawa
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshinori Hyodo
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eri Asano
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoko Ito
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masao Maeda
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hirokazu Kuribayashi
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Natsume
2Department of Neurosurgery, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshihiko Wakabayashi
2Department of Neurosurgery, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michinari Hamaguchi
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Senga
1Division of Cancer Biology, Nagoya University, Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya466-8550, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tsenga@med.nagoya-u.ac.jp
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    SVIL is a cytokinesis-associated protein. (A) HeLa cells cultured on 24-well plates were transfected with siRNAs, and 72 hours later, the ratio of multinucleated cells was evaluated. In the first screen, two different siRNAs were used for 88 genes. In the second screen, four different siRNAs were used for the indicated genes. The graph shows the ratio of multinucleated cells after treatment with each siRNA. Two independent experiments were performed for the first and second screen. (B) The cells were transfected with siRNAs, and 72 hours later, the cells were lysed and immunoblotted with anti-SVIL antibody. (C) The cells were transfected with GFP-SVIL, GFP-SVIL-Res#1, or GFP-SVIL-Res#2 together with the indicated siRNAs, and 72 hours later, the cells were lysed and immunoblotted using the indicated antibodies. GFP-SVIL-Res#1 has silent mutations to confer resistance to SVIL siRNA #1 and GFP-SVIL-Res#2 to SVIL siRNA#2. (D) The cells were treated as in C, and the ratio of multinucleated cells was evaluated. Three independent experiments were performed, and 200 cells were evaluated for each experiment (for this and all subsequent figures the data are means ± s.d.; **P<0.01, n.s; not significant). (E) HeLa cells were fixed with methanol/acetone and immunostained for SVIL, α-tubulin and the nucleus (Hoechst). Ana1, Ana2 and Ana3 are different stages in anaphase.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    PLK1 phosphorylates Ser238 of SVIL. (A) The cells were synchronized by double thymidine block and lysed at the indicated time points. The cell lysates were separated by SDS-PAGE with Phos-tag. The graph shows the relative thickness of each band of SVIL. (B) Ser238 of SVIL is in the consensus sequence of PLK1 phosphorylation. (C) HA-tagged full-length and deletion mutants of SVIL were expressed in HEK293T cells with or without GFP–PLK1, and the mobility shift was examined by immunoblotting. (D) HA-tagged aa1–345 SVIL was expressed in HEK293T cells together with wild-type or kinase-dead (K82M) PLK1 and immunoprecipitated with anti-HA antibody. The immunoprecipitates were treated with or without λ-phosphatase, and the mobility shift was examined by immunoblotting. (E) HA-tagged aa1–345 of wild-type or S238A-SVIL was expressed in HEK293T cells with wild-type or kinase-dead PLK1, and the mobility shift was examined by immunoblotting. (F) GST-fused residues 228–256 of wild-type or S238A-SVIL was incubated with PLK1 for 30 minutes at 30°C in the presence of [γ-32P]ATP and separated by SDS-PAGE. The upper panel shows the phosphorylation of recombinant proteins, and the lower panel shows Coomassie Blue (CBB) staining of the recombinant proteins. The arrow in the upper panel indicates the phosphorylated GST-SVIL (aa228–256). The arrow in the lower panel indicates GST–SVIL (aa228–256). The asterisks indicate degraded forms of GST–SVIL (aa228–256), and the arrowhead indicates GST. (G) HA-tagged full-length SVIL was transiently expressed in HEK293T cells and immunoprecipitated with anti-HA antibody and subjected to an in vitro kinase assay. The arrow indicates phosphorylated SVIL.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    PLK1 is required for the localization of SVIL to the central spindle. (A) Nocodazole-arrested HeLa cells were released in the presence of 25 µM of MG132 for 1 hour. Cells were then incubated with DMSO or PLK1 inhibitor for 1 hour. The cells were fixed with methanol/acetone and immunostained for the indicated proteins. The graph shows the ratio of cells with SVIL at the central spindle (n = 30, **P<0.01). (B) HeLa cells transfected with GFP-tagged wild-type or ST4AA-PRC1 were nocodazole-arrested and released. The cells were fixed with methanol/acetone and immunostained for the indicated proteins. In ST4AA-PRC, Ser577, Thr578, Ser601 and Thr602 were replaced with alanines. The graph shows the ratio of cells with SVIL at the central spindle (n = 30, **P<0.01).

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    SVIL associates with PRC1. (A) GFP-tagged full-length and deletion mutants of SVIL were expressed in HEK293T cells together with HA–PRC1 and immunoprecipitated with anti-HA antibody. The immunoprecipitates were subjected to immunoblotting with the indicated antibodies. (B) GFP-tagged full-length and deletion mutants of PRC1 were expressed in HEK293T cells together with HA–SVIL and immunoprecipitated with anti-HA antibody. The immunoprecipitates were subjected to immunoblotting with anti-HA and anti-GFP antibodies. (C) In vitro translated HA–SVIL (aa676–1009) was affinity precipitated with GST or GST-fused residues 1–200 of PRC1 bound to glutathione–agarose beads. The precipitates were subjected to immunoblotting with anti-HA antibody. The lower panel shows Coomassie Blue staining of recombinant proteins. (D) Double thymidine-blocked HeLa cells were released and lysed at the indicated time points. The cell lysates were immunoprecipitated with anti-SVIL antibody, and the immunoprecipitates were blotted with the indicated antibodies.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Phosphorylation of Ser238 regulates the interaction of SVIL and PRC1. (A) HA–SVIL was expressed in HEK293T cells with GFP-tagged wild-type or kinase-dead PLK1, and phosphorylated or non-phosphorylated HA–SVIL was affinity precipitated by anti-HA antibody. The precipitates were mixed with lysates of HeLa cells that transiently expressed GFP–PRC1, and proteins bound to HA–SVIL were affinity precipitated and subjected to immunoblot analysis. Band intensities were measured using ImageJ software, and the relative intensities are indicated. (B) HA-tagged wild-type, S238A- and S238D-SVIL were transiently expressed in HEK293T cells with GFP–PRC1. The cells were lysed and immunoprecipitated with anti-HA antibody. The immunoprecipitates were blotted with anti-HA and anti-GFP antibody. The relative band intensities are indicated. (C) GFP-tagged wild-type, ST4AA-, ST4DD-PRC1 were transiently expressed in HEK293T cells with HA–SVIL. The cells were lysed and immunoprecipitated with anti-HA antibody. The immunoprecipitates were blotted with anti-HA and anti-GFP antibodies. (D) HeLa cells that constitutively expressed GFP-tagged wild-type, S238A- and S238D-SVIL were fixed with methanol/acetone and immunostained for GFP and PRC1. (E) The fluorescence intensities across the anaphase cells, as indicated by the dashed white lines in D, were measured using ImageJ software (n = 10).

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    SVIL is required to confine the furrow in the restricted zone. (A) MCF10A cells that constitutively expressed both GFP–RLC and DsRed–H2B were transfected with siRNAs. Twenty-four hours later, cell division was monitored by time-lapse microcopy. (B) The ratio of the furrow length (furrow) to the distance between the polar cortexes (total) was measured. The ratio of furrow/total of each cell was plotted, and the average ratios are indicated in the graph (**P<0.01). (C) MCF10A cells that constitutively expressed siRNA-resistant GFP-tagged wild-type, S238A- and S238D-SVIL were established. The cells were transfected with SVIL siRNA to deplete endogenous protein, and cell division was monitored by time-lapse microscopy. (D) The ratio of furrow/total was evaluated for each cell and plotted on the graph. The average ratios are indicated (**P<0.01, n.s; not significant). (E) Schematic representation of ΔAct-SVIL and ΔAyo-SVIL. (F) MCF10A cells that constitutively expressed siRNA-resistant GFP-tagged wild-type, ΔAct- and ΔMyo-SVIL were established, and endogenous SVIL was depleted by siRNA transfection. The ratio of furrow/total was evaluated in each cell and plotted on the graph. The average ratios are indicated by horizontal bars (**P<0.01, n.s; not significant).

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    SVIL regulates the activation of myosin II at the cleavage furrow. (A) HeLa cells transfected with control or SVIL siRNA were nocodazole-arrested and released. The cells were lysed at the indicated time points, and the phosphorylation of RLC was examined by immunoblot. (B) HeLa cells, transfected with siRNAs, were fixed with 4% paraformaldehyde and immunostained. The graph shows the ratio of cells with phosphorylated RLC at the equatorial cortex (n = 30). (C) HeLa cells that constitutively expressed siRNA-resistant GFP-tagged wild-type, ΔAct- and ΔMyo-SVIL were generated and transfected with SVIL siRNA. The cells were fixed with methanol/acetone or 4% paraformaldehyde and immunostained. Note that the methanol/acetone-fixed cells and paraformaldehyde-fixed cells are different. The graph shows the ratio of cells with phosphorylated RLC at the equatorial cortex (n = 30). (D) HeLa cells that constitutively expressed siRNA-resistant GFP-tagged wild-type, S238A- and S238D-SVIL were established and transfected with SVIL siRNA. The cells were fixed with 4% paraformaldehyde and immunostained. Note that the central spindle localization of SVIL is not visible after 4% paraformaldehyde fixation. The graph shows the ratio of cells with phosphorylated RLC at the equatorial cortex (n = 30). (E) Schematic representation of PLK1-mediated myosin II activation at the cleavage furrow.

Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

Keywords

  • Cytokinesis
  • Central spindle
  • Plk1
  • SVIL
  • Phosphorylation

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing
Hitoki Hasegawa, Toshinori Hyodo, Eri Asano, Satoko Ito, Masao Maeda, Hirokazu Kuribayashi, Atsushi Natsume, Toshihiko Wakabayashi, Michinari Hamaguchi, Takeshi Senga
Journal of Cell Science 2013 126: 3627-3637; doi: 10.1242/jcs.124818
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
The role of PLK1-phosphorylated SVIL in myosin II activation and cytokinetic furrowing
Hitoki Hasegawa, Toshinori Hyodo, Eri Asano, Satoko Ito, Masao Maeda, Hirokazu Kuribayashi, Atsushi Natsume, Toshihiko Wakabayashi, Michinari Hamaguchi, Takeshi Senga
Journal of Cell Science 2013 126: 3627-3637; doi: 10.1242/jcs.124818

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Summary
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • Vacuolar protein Tag1 and Atg1–Atg13 regulate autophagy termination during persistent starvation in S. cerevisiae
  • Aberrant cytoplasmic localization of ARID1B activates ERK signaling and promotes oncogenesis
  • Importin-9 regulates chromosome segregation and packaging in Drosophila germ cells
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

Introducing FocalPlane’s new Community Manager, Esperanza Agullo-Pascual

We are pleased to welcome Esperanza to the Journal of Cell Science team. The new Community Manager for FocalPlane, Esperanza is joining us from the Microscopy Core at Mount Sinai School of Medicine. Find out more about Esperanza in her introductory post over on FocalPlane.


New funding scheme supports sustainable events

As part of our Sustainable Conferencing Initiative, we are pleased to announce funding for organisers that seek to reduce the environmental footprint of their event. The next deadline to apply for a Scientific Meeting grant is 26 March 2021.


Read & Publish participation continues to grow

"Alongside pre-printing for early documentation of work, such mechanisms are particularly helpful for early-career researchers like me.”

Dr Chris MacDonald (University of York) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 150 institutions in 15 countries and four library consortia taking part – find out more and view our full list of participating institutions.


Cell scientist to watch: Romain Levayer

In an interview, Romain Levayer talks about starting his own lab, his love for preprints and his experience of balancing parenting with his research goals.


Live lactating mammary tissue

In a stunning video, Stewart et al. demonstrate warping of the alveolar unit due to basal cell-generated force as part of their recent work investigating roles for mechanically activated ion channels in lactation and involution.

Visit our YouTube channel to watch more videos from JCS, our sister journals and the Company.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992